Skip to main content
. 2012 Sep 17;7:158. doi: 10.1186/1748-717X-7-158

Table 2.

Late toxicity for localized prostate cancer patients with respect to treatment arm (IG-IMRT vs. RP followed by IMRT)

Toxicity
Total
IG-IMRT
RP + IMRT
p-value
  (n= 96) (n= 49) (n= 47)  
Genitourinary
0.145
G0
30 (31.3%)
11 (22.5%)
19 (40.4%)
G1
25 (26.0%)
17 (34.7%)
8 (17.0%)
G2
24 (25.0%)
12 (24.5%)
12 (25.5%)
G3
17 (17.7%)
9 (18.4%)
8 (17.0%)
G4
-
-
-
Gastrointestinal
0.095
G0
85 (88.5%)
42 (85.7%)
43 (91.5%)
G1
9 (9.4%)
7 (14.3%)
2 (4.3%)
G2
-
-
-
G3
2 (2.1%)
-
2 (4.3%)
G4   - -